These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6827546)
1. 2'-O-nitro-1-beta-D-arabinofuranosylcytosine. A new derivative of 1-beta-D-arabinofuranosylcytosine that resists enzymatic deamination and has antileukemic activity. Chwang TL; Fridland A; Avery TL J Med Chem; 1983 Feb; 26(2):280-3. PubMed ID: 6827546 [TBL] [Abstract][Full Text] [Related]
2. Effect and mode of action of N4-behenoyl-beta-D-arabinofuranosylcytosine. Kataoka T; Sakurai Y Recent Results Cancer Res; 1980; 70():147-51. PubMed ID: 7355245 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity studies in vivo of liposomal phospholipid-N4-palmitoyl- and N4-hexadecyl-1-beta-D-arabinofuranosylcytosine conjugates. Schott H; Schwendener RA Anticancer Drug Des; 1996 Sep; 11(6):451-62. PubMed ID: 8836110 [TBL] [Abstract][Full Text] [Related]
4. Nucleoside conjugates. 10. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine 5'-diphosphate-1,2-dipalmitins. Hong CI; An SH; Schliselfeld L; Buchheit DJ; Nechaev A; Kirisits AJ; West CR J Med Chem; 1988 Sep; 31(9):1793-8. PubMed ID: 3411602 [TBL] [Abstract][Full Text] [Related]
5. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid. Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392 [TBL] [Abstract][Full Text] [Related]
6. Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids. Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR J Med Chem; 1990 May; 33(5):1380-6. PubMed ID: 2329558 [TBL] [Abstract][Full Text] [Related]
7. Antileukemic activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, a new depot form of 1-beta-D-arabinofuranosylcytosine. Khwaja TA; Kigwana LJ; Mian AM Cancer Res; 1979 Aug; 39(8):3129-33. PubMed ID: 455296 [No Abstract] [Full Text] [Related]
8. 1-beta-D-arabinofuranosylcytosine-phospholipid conjugates as prodrugs of Ara-C. Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Ryu EK; MacCoss M Cancer Drug Deliv; 1984; 1(3):181-90. PubMed ID: 6544120 [TBL] [Abstract][Full Text] [Related]
9. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice. Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034 [TBL] [Abstract][Full Text] [Related]
10. Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids. Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Berdel WE J Med Chem; 1986 Oct; 29(10):2038-44. PubMed ID: 3761322 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia. Momparler RL; Momparler LF; Samson J Leuk Res; 1984; 8(6):1043-9. PubMed ID: 6083417 [TBL] [Abstract][Full Text] [Related]
12. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance. Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444 [TBL] [Abstract][Full Text] [Related]
13. 1-beta-D-arabinofuranosylcytosine conjugates of corticosteroids as potential antitumor agents. Hong CI; Nechaev A; Kirisits AJ; Buchheit DJ; West CR Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1105-12. PubMed ID: 6684555 [TBL] [Abstract][Full Text] [Related]
14. Activity of 2-fluoro-5-methylarabinofuranosyluracil against mouse leukemias sensitive to and resistant to 1-beta-D-arabinofuranosylcytosine. Burchenal JH; Chou TC; Lokys L; Smith RS; Watanabe KA; Su TL; Fox JJ Cancer Res; 1982 Jul; 42(7):2598-600. PubMed ID: 7083153 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative. Kato Y; Saito M; Fukushima H; Takeda Y; Hara T Cancer Res; 1984 Jan; 44(1):25-30. PubMed ID: 6197162 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate-induced changes in the levels of 1-beta-D-arabinofuranosylcytosine triphosphate in L1210 cells. Roberts D; Peck C; Hilliard S; Wingo W Cancer Res; 1979 Oct; 39(10):4048-54. PubMed ID: 476642 [TBL] [Abstract][Full Text] [Related]
17. Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine. Horber DH; Schott H; Schwendener RA Br J Cancer; 1995 May; 71(5):957-62. PubMed ID: 7734320 [TBL] [Abstract][Full Text] [Related]
18. 1-beta-D-arabinofuranosylcytosine conjugates of ether and thioether phospholipids. A new class of ara-C prodrug with improved antitumor activity. Hong CI; West CR; Bernacki RJ; Tebbi CK; Berdel WE Lipids; 1991 Dec; 26(12):1437-44. PubMed ID: 1819747 [TBL] [Abstract][Full Text] [Related]
19. N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent. Aoshima M; Tsukagoshi S; Sakurai Y; Oh-ishi JI; Ishida T Cancer Res; 1977 Aug; 37(8 Pt 1):2481-6. PubMed ID: 872077 [TBL] [Abstract][Full Text] [Related]
20. Lipophilic 5'-(alkyl phosphate) esters of 1-beta-D-arabinofuranosylcytosine and its N4-acyl and 2,2'-anhydro-3'-O-acyl derivatives as potential prodrugs. Rosowsky A; Kim SH; Ross J; Wick MM J Med Chem; 1982 Feb; 25(2):171-8. PubMed ID: 7057424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]